Across the United Kingdom antidepressants have become one of the most widely prescribed categories of medication. Drugs such as sertraline, citalopram and fluoxetine are now deeply embedded in modern healthcare and are commonly introduced during periods when someone feels overwhelmed by anxiety, depression, grief or prolonged emotional stress. In those moments the focus is understandably on immediate relief and stabilisation. Yet what is rarely explored in any meaningful depth is what happens when these medicines become part of a person’s nervous system not for months, but for decades.

The nervous system is not a static structure that remains unchanged throughout life. It is a living, adaptive network that responds continuously to the signals it receives from the body and the environment. Nutritional status, stress hormones, inflammatory molecules, gut bacteria, toxins, emotional experience and relational life all influence the way neurons communicate with one another. When medication alters neurotransmitter signalling, the brain adapts around that change. Over time the nervous system reorganises itself within that new biochemical landscape.

Selective serotonin reuptake inhibitors work by modifying the way serotonin circulates between nerve cells. Serotonin is often described simply as a mood chemical, yet its influence extends far beyond emotional regulation. It participates in sleep cycles, appetite, digestion, pain perception, thermoregulation and aspects of cognition. When serotonin signalling is altered pharmacologically the effects ripple outward through many other systems in the brain and body.

This becomes particularly significant when we consider the ageing brain. In recent years researchers studying dementia have begun examining how long term antidepressant use interacts with cognitive decline. Dementia reflects gradual changes in neuronal communication, metabolic stress within brain cells, increased inflammation and reduced resilience within the brain’s delicate signalling networks. When medications that influence neurotransmitters remain part of the nervous system for many years, they become one factor within that wider biological terrain.

In my work I always look at the nervous system through multiple lenses. I am interested in the terrain that has shaped a person across time, including their genetics, methylation pathways, detoxification capacity, mineral balance, gut health, inflammatory burden, neurotransmitter patterns, oxidative stress and the lived experiences that have shaped their nervous system throughout life. When these layers are brought together, a much deeper understanding begins to emerge of why one nervous system remains resilient while another becomes overwhelmed or cognitively burdened.

Genetic testing often forms the starting point for this exploration. Through LifeCode Gx reports we can examine variations in genes that influence methylation, neurotransmitter metabolism, detoxification pathways and inflammatory signalling. These genetic patterns do not determine destiny, but they frequently illuminate why two individuals may respond very differently to stress, medication or environmental exposures. Some people carry genetic variations that influence serotonin transport or dopamine receptor sensitivity. Others have patterns affecting how efficiently the body clears inflammatory molecules or neutralises oxidative stress within brain tissue.

Laboratory investigations such as organic acid testing and mineral analysis then deepen that picture. Organic acid tests can reveal disruptions in neurotransmitter metabolism, mitochondrial stress, microbial byproducts and metabolic pathways that influence mood and cognition. Hair mineral analysis frequently uncovers imbalances in magnesium, zinc, copper and other trace elements that quietly shape nervous system signalling. These patterns often remain invisible in standard medical assessments yet they can exert a profound influence on neurological resilience.

When these biological layers are addressed through nutritional therapy, microbiome restoration, targeted supplementation and careful nervous system regulation, the brain sometimes begins to stabilise in ways that surprise both patients and practitioners. The nervous system is extraordinarily responsive when the terrain supporting it begins to shift.

Looking back across the timeline of someone’s life often reveals a far more complex story than a simple diagnosis of depression or anxiety. A medication may have entered the picture during a moment of emotional crisis, yet the decades that followed involved continual adaptation by the nervous system to that altered biochemical environment. When cognitive decline begins to appear later in life, it becomes impossible to understand the present without considering the entire biological and environmental journey that preceded it.

Understanding that longer story is central to the way I work with individuals and families. Rather than focusing on symptoms alone, we explore the biological terrain that has shaped the nervous system across time. In doing so, a different kind of conversation begins to emerge about brain health, ageing and the long arc of the human nervous system.